Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475332 · ClinicalTrials.gov registry record · Phase 2
Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
A Phase 2 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00475332 is a Phase 2 study that was terminated before completion, run by University of Florida. The registered enrollment target is 2 participants.
The verdict
NCT00475332, a Phase 2 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of treating relapsed follicular lymphoma with a combination of Bexxar and External Beam Radiotherapy (EBRT). Patients will receive EBRT (20 Gy in 10 fractions) followed by Bexxar.
Interventions
- PROCEDURE External Beam Radiation Therapy
- DRUG Iodine I -01 Tositumomab (Bexxar)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00475332
The ClinicalTrials.gov registry entry for NCT00475332 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which External Beam Radiation Therapy is the first listed.
NCT00475332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00475332 about?
NCT00475332 is a clinical study titled "Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar". The purpose of this study is to determine the feasibility of treating relapsed follicular lymphoma with a combination of Bexxar and External Beam Radiotherapy (EBRT). Patients will receive EBRT (20 Gy in 10 fractions) followed by Bexxar.
What is the current status of trial NCT00475332?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2007-09. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00475332?
The interventions under investigation include: External Beam Radiation Therapy (PROCEDURE), Iodine I -01 Tositumomab (Bexxar) (DRUG).
Who is sponsoring clinical trial NCT00475332?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.